Evidence map›Paper›PMID 34649516›Full record

ArticleBMC microbiology2021

Cultivation of common bacterial species and strains from human skin, oral, and gut microbiota.

Elizabeth Fleming, Victor Pabst, Zoe Scholar, Ruoyun Xiong, Anita Y Voigt, Wei Zhou, Amelia Hoyt, Rachel Hardy, Anna Peterson, Ryan Beach and 5 more

Abstract read
In one paragraph

Article in BMC microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Application of Culturomics to Explore African Skin Microbiota.The American journal of tropical medicine and hygiene · 2024
    Article
  7. Diversity of Neurotransmitter-Producing Human Skin Commensals.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Frontiers in nutrition · 2023
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elizabeth Fleming *The Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Victor Pabst *The Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Zoe ScholarThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Ruoyun XiongThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Anita Y VoigtThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Wei ZhouThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Amelia HoytThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Rachel HardyThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Anna PetersonThe University of Connecticut Health Center, Farmington, CT, USA.
Ryan BeachThe University of Connecticut Health Center, Farmington, CT, USA.
Yvette Ondouah-NzutchiThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Jinhong DongThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA.
Lucinda BatemanBateman Horne Center, Salt Lake City, UT, 84102, USA.
Suzanne D VernonBateman Horne Center, Salt Lake City, UT, 84102, USA.
Julia OhThe Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 860-837-2014, USA. julia.oh@jax.org.ORCID 0000-0002-5534-7023

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Anna Karolina Palucka · 1985 to 2026
$61.9M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Adolfo Garcia-Sastre, Anna Karolina Palucka · 2019 to 2026
$23.1M
Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms - Clinical Research ProjectU54NS105539 · NINDS · JACKSON LABORATORY · PI UNUTMAZ, DERYA · 2017 to 2022
$10.6M
Metagenomes to Therapeutics: Defining the Rules for Engineering the Skin MicrobiomeDP2GM126893 · NIGMS · JACKSON LABORATORY · PI OH, JULIA · 2017 to 2017
$2.8M
Molecular Mechanisms of Staphylococcus Epidermidis Strain DiversityR01AR078634 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2021 to 2025
$2.5M
Microbiome Plasticity and Pathogenicity in Older Adults: Baselines and Transitions from Skilled Nursing CareR56AG060746 · NIA · JACKSON LABORATORY · PI KUCHEL, GEORGE A, OH, JULIA · 2019 to 2019
$779k
Skin Microbiome of Monogenic Skin DisordersR21AR075174 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2019 to 2022
$466k
Community organizing: Harnessing the interactions of the microbiome as a basis for novel therapeutic strategiesK22AI119231 · NIAID · JACKSON LABORATORY · PI OH, JULIA · 2016 to 2017
$270k
NCI NIH HHS P30 CA034196NIAID NIH HHS K22 AI119231NIAID NIH HHS U19 AI142733NIAMS NIH HHS R01 AR078634NIAMS NIH HHS R21 AR075174NIA NIH HHS R56 AG060746NIGMS NIH HHS DP2 GM126893NINDS NIH HHS U54 NS105539
6 · The paper itself

Abstract

backgroundGenomics-driven discoveries of microbial species have provided extraordinary insights into the biodiversity of human microbiota. In addition, a significant portion of genetic variation between microbiota exists at the subspecies, or strain, level. High-resolution genomics to investigate species- and strain-level diversity and mechanistic studies, however, rely on the availability of individual microbes from a complex microbial consortia. High-throughput approaches are needed to acquire and identify the significant species- and strain-level diversity present in the oral, skin, and gut microbiome. Here, we describe and validate a streamlined workflow for cultivating dominant bacterial species and strains from the skin, oral, and gut microbiota, informed by metagenomic sequencing, mass spectrometry, and strain profiling.

resultsOf total genera discovered by either metagenomic sequencing or culturomics, our cultivation pipeline recovered between 18.1-44.4% of total genera identified. These represented a high proportion of the community composition reconstructed with metagenomic sequencing, ranging from 66.2-95.8% of the relative abundance of the overall community. Fourier-Transform Infrared spectroscopy (FT-IR) was effective in differentiating genetically distinct strains compared with whole-genome sequencing, but was less effective as a proxy for genetic distance.

conclusionsUse of a streamlined set of conditions selected for cultivation of skin, oral, and gut microbiota facilitates recovery of dominant microbes and their strain variants from a relatively large sample set. FT-IR spectroscopy allows rapid differentiation of strain variants, but these differences are limited in recapitulating genetic distance. Our data highlights the strength of our cultivation and characterization pipeline, which is in throughput, comparisons with high-resolution genomic data, and rapid identification of strain variation.

Indexed as

BacteriaBacteriological TechniquesGastrointestinal MicrobiomeGenome, BacterialHumansMouthSkin

Identifiers

PMID34649516
PMCPMC8515726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.